This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: Identification of compound heterozygous variants in OPTN in an ALS-FTD patient from the CReATe consortium: a case report, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, March 2018, Taylor & Francis,
DOI: 10.1080/21678421.2018.1452947.
You can read the full text:
The following have contributed to this page
